Biomax Informatics AG and Molecular Networks GmbH Announce Product Development Alliance

Biomax Informatics AG and Molecular Networks GmbH Announce Product Development Alliance

Martinsried and Erlangen, Germany – July 9, 2001 – Biomax Informatics and Molecular Networks announce today the formation of a strategic partnership that will effectively join bioinformatics and chemoinformatics into one stream of research. Molecular Networks, which specializes in the development of software for drug design, combinatorial chemistry, and data-mining, and Biomax, with its expertise in DNA and protein sequence analysis used in drug-target design and database integration, will collaborate in the development of software tools for optimized drug-target lead generation and validation.

We use cookies on our website to enhance the user experience and to analyze traffic. We may share your site usage data with our analytics software providers. By clicking “Accept & Close,” you are consenting to the terms described on our Disclaimer page.